By Scientia Professor Louisa Jane Degenhardt

Journal articles

Wong RXY; Farrell M; Degenhardt L; Memedovic S; Harvey SB; Petrie K, 2023, 'Substance use among vocational trainees in Australia: differences between medical specialties', Internal Medicine Journal, 53, pp. 939 - 945, http://dx.doi.org/10.1111/imj.15729

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002

Johnson EC; Colbert SMC; Jeffries PW; Tillman R; Bigdeli TB; Karcher NR; Chan G; Kuperman S; Meyers JL; Nurnberger JI; Plawecki MH; Degenhardt L; Martin NG; Kamarajan C; Schuckit MA; Murray RM; Dick DM; Edenberg HJ; D’Souza DC; Forti MD; Porjesz B; Nelson EC; Agrawal A, 2023, 'Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users', Schizophrenia Bulletin, 49, pp. 778 - 787, http://dx.doi.org/10.1093/schbul/sbac196

Bharat C; Glantz MD; Aguilar-Gaxiola S; Alonso J; Bruffaerts R; Bunting B; Caldas-de-Almeida JM; Cardoso G; Chardoul S; de Jonge P; Gureje O; Haro JM; Harris MG; Karam EG; Kawakami N; Kiejna A; Kovess-Masfety V; Lee S; McGrath JJ; Moskalewicz J; Navarro-Mateu F; Rapsey C; Sampson NA; Scott KM; Tachimori H; ten Have M; Vilagut G; Wojtyniak B; Xavier M; Kessler RC; Degenhardt L, 2023, 'Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use', Addiction, 118, pp. 954 - 966, http://dx.doi.org/10.1111/add.16122

Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J, 2023, 'Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e659 - e672, http://dx.doi.org/10.1016/S2214-109X(23)00057-8

Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e673 - e683, http://dx.doi.org/10.1016/S2214-109X(23)00058-X

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

Bharat C; Degenhardt L; Pearson SA; Buizen L; Wilson A; Dobbins T; Gisev N, 2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567

Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A, 2023, 'Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis', Drug and Alcohol Review, 42, pp. 569 - 581, http://dx.doi.org/10.1111/dar.13595

Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A, 2023, 'Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions', International Journal of Drug Policy, 113, http://dx.doi.org/10.1016/j.drugpo.2023.103976

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Santo T; Gisev N; Campbell G; Nelson E; Degenhardt L, 2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2023, 'Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103917

Conigrave JH; Wilson S; Conigrave KM; Chikritzhs T; Hayman N; Dawson A; Ali R; Perry J; Fitts MS; Degenhardt L; Doyle M; Egert S; Slade T; Ezard N; Dzidowska M; Lee KSK, 2022, '‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians', Addiction Science and Clinical Practice, 17, http://dx.doi.org/10.1186/s13722-022-00298-2

Hopkins RE; Degenhardt L; Campbell G; Farnbach S; Gisev N, 2022, '“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-08946-8

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Gaddis N; Mathur R; Marks J; Zhou L; Quach B; Waldrop A; Levran O; Agrawal A; Randesi M; Adelson M; Jeffries PW; Martin NG; Degenhardt L; Montgomery GW; Wetherill L; Lai D; Bucholz K; Foroud T; Porjesz B; Runarsdottir V; Tyrfingsson T; Einarsson G; Gudbjartsson DF; Webb BT; Crist RC; Kranzler HR; Sherva R; Zhou H; Hulse G; Wildenauer D; Kelty E; Attia J; Holliday EG; McEvoy M; Scott RJ; Schwab SG; Maher BS; Gruza R; Kreek MJ; Nelson EC; Thorgeirsson T; Stefansson K; Berrettini WH; Gelernter J; Edenberg HJ; Bierut L; Hancock DB; Johnson EO, 2022, 'Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-21003-y

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Gmelin JOH; De Vries YA; Baams L; Aguilar-Gaxiola S; Alonso J; Borges G; Bunting B; Cardoso G; Florescu S; Gureje O; Karam EG; Kawakami N; Lee S; Mneimneh Z; Navarro-Mateu F; Posada-Villa J; Rapsey C; Slade T; Stagnaro JC; Torres Y; Kessler RC; de Jonge P; Al-Hamzawi A; Alonso J; Andrade LH; Atwoli L; Benjet C; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; Chatterji S; Cia AH; Degenhardt L; Demyttenaere K; Florescu S; de Girolamo G; Haro JM; Harris M; Hinkov H; Hu CY; de Jonge P; Karam AN; Kawakami N; Kiejna A; Kovess-Masfety V; Lee S; Lepine JP; McGrath J; Medina-Mora ME; Moskalewicz J; Piazza M; Posada-Villa J; Scott KM; Stein DJ; Have MT; Viana MC; Vigo DV; Whiteford H; Wojtyniak B, 2022, 'Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys', Social Psychiatry and Psychiatric Epidemiology, 57, pp. 2319 - 2332, http://dx.doi.org/10.1007/s00127-022-02320-z

Degenhardt L; Bharat C; Glantz MD; Bromet EJ; Alonso J; Bruffaerts R; Bunting B; de Girolamo G; de Jonge P; de Jonge P; Florescu S; Gureje O; Haro JM; Harris MG; Hinkov H; Karam EG; Karam G; Kovess-Masfety V; Lee S; Makanjuola V; Medina-Mora ME; Navarro-Mateu F; Piazza M; Posada-Villa J; Scott KM; Stein DJ; Tachimori H; Tintle N; Torres Y; Viana MC; Kessler RC; Aguilar-Gaxiola S; Al-Hamzawi A; Al-Kaisy MS; Altwaijri Y; Helena Andrade L; Atwoli L; Benjet C; Borges G; Caldas-de-Almeida JM; Cardoso G; Chatterji S; Cia AH; Demyttenaere K; Hu CY; Karam AN; Kawakami N; Kiejna A; Lee S; Lepine JP; McGrath J; Mneimneh Z; Moskalewicz J; Posada-Villa J; Slade T; Stagnaro JC; ten Have M; Vigo DV; Whiteford H; Williams DR; Wojtyniak B, 2022, 'The associations between traumatic experiences and subsequent onset of a substance use disorder: Findings from the World Health Organization World Mental Health surveys', Drug and Alcohol Dependence, 240, http://dx.doi.org/10.1016/j.drugalcdep.2022.109574

Bruffaerts R; Harris MG; Kazdin AE; Vigo DV; Sampson NA; Chiu WT; Al-Hamzawi A; Alonso J; Altwaijri YA; Andrade L; Benjet C; de Girolamo G; Florescu S; Haro JM; Hu CY; Karam A; Karam EG; Kovess-Masfety V; Lee S; McGrath JJ; Navarro-Mateu F; Nishi D; O’Neill S; Posada-Villa J; Scott KM; Have MT; Torres Y; Wojtyniak B; Xavier M; Zarkov Z; Kessler RC; Aguilar-Gaxiola S; Al-Kaisy MS; Andrade LH; Atwoli L; Borges G; Bromet EJ; Bunting B; Caldas-de-Almeida JM; Cardoso G; Chatterji S; Cia AH; Degenhardt L; Demyttenaere K; Gureje O; Hinkov H; de Jonge P; Kawakami N; Kiejna A; Lepine JP; Medina-Mora ME; Mneimneh Z; Moskalewicz J; Piazza M; Slade T; Stagnaro JC; Stein DJ; Viana MC; Whiteford H, 2022, 'Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys', Social Psychiatry and Psychiatric Epidemiology, 57, pp. 2079 - 2095, http://dx.doi.org/10.1007/s00127-022-02249-3

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Santo T; Campbell G; Gisev N; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L, 2022, 'Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109551

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Jones N; Degenhardt L; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1787

Leung J; Santo T; Colledge-Frisby S; Mekonen T; Thomson K; Degenhardt L; Connor JP; Hall W; Stjepanović D, 2022, 'Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies', Pain Medicine United States, 23, pp. 1442 - 1456, http://dx.doi.org/10.1093/pm/pnac029

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555

Saha S; Lim CCW; Degenhardt L; Cannon DL; Bremner M; Prentis F; Lawrence Z; Heffernan E; Meurk C; Reilly J; McGrath JJ, 2022, 'Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis', Australian and New Zealand Journal of Psychiatry, 56, pp. 757 - 770, http://dx.doi.org/10.1177/00048674211054740

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Farrell M; Hickman M; Webster D; Hayward A; Degenhardt L, 2022, 'Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia', Plos Medicine, 19, pp. e1004049, http://dx.doi.org/10.1371/journal.pmed.1004049

Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N, 2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, 105, http://dx.doi.org/10.1016/j.drugpo.2022.103708

Jones NR; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R; Degenhardt L, 2022, 'The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001–2018: Findings from the OATS retrospective linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109464

Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494

Man N; Sisson SA; McKetin R; Chrzanowska A; Bruno R; Dietze PM; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A, 2022, 'Trends in methamphetamine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, 41, pp. 1041 - 1052, http://dx.doi.org/10.1111/dar.13468

Kessler RC; Kazdin AE; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Altwaijri YA; Andrade LH; Benjet C; Bharat C; Borges G; Bruffaerts R; Bunting B; de Almeida JMC; Cardoso G; Chiu WT; Cía A; Ciutan M; Degenhardt L; de Girolamo G; de Jonge P; de Vries Y; Florescu S; Gureje O; Haro JM; Harris MG; Hu C; Karam AN; Karam EG; Karam G; Kawakami N; Kiejna A; Kovess-Masfety V; Lee S; Makanjuola V; McGrath J; Medina-Mora ME; Moskalewicz J; Navarro-Mateu F; Nierenberg AA; Nishi D; Ojagbemi A; Oladeji BD; O'Neill S; Posada-Villa J; Puac-Polanco V; Rapsey C; Ruscio AM; Sampson NA; Scott KM; Slade T; Stagnaro JC; Stein DJ; Tachimori H; ten Have M; Torres Y; Viana MC; Vigo DV; Williams DR; Wojtyniak B; Xavier M; Zarkov Z; Ziobrowski HN, 2022, 'Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys', World Psychiatry, 21, pp. 272 - 286, http://dx.doi.org/10.1002/wps.20971

Hopkins RE; Campbell G; Degenhardt L; Nielsen S; Blyth F; Cohen M; Gisev N, 2022, 'Use of pharmacological and nonpharmacological treatments for chronic noncancer pain among people using opioids: a longitudinal cohort study', Pain, 163, pp. 1049 - 1059, http://dx.doi.org/10.1097/j.pain.0000000000002484

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J, 2022, 'Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis', Lancet Gastroenterology and Hepatology, 7, pp. 426 - 445, http://dx.doi.org/10.1016/S2468-1253(21)00471-4

Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736

Leung J; Chan GCK; Tan SX; McClure-Thomas C; Degenhardt L; Hall W, 2022, 'State-Level Prevalence and Associates of Opioid Dependence in the USA', International Journal of Environmental Research and Public Health, 19, http://dx.doi.org/10.3390/ijerph19073825

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Padmanathan P; Forbes H; Redaniel MT; Gunnell D; Lewer D; Moran P; Watson B; Degenhardt L; Hickman M, 2022, 'Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study', Lancet Psychiatry, 9, pp. 151 - 159, http://dx.doi.org/10.1016/S2215-0366(21)00392-8

Stone J; Artenie A; Hickman M; Martin NK; Degenhardt L; Fraser H; Vickerman P, 2022, 'The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study', Lancet Public Health, 7, pp. e136 - e145, http://dx.doi.org/10.1016/S2468-2667(21)00258-9

Ferrari AJ; Santomauro DF; Herrera AMM; Shadid J; Ashbaugh C; Erskine HE; Charlson FJ; Degenhardt L; Scott JG; McGrath JJ; Allebeck P; Benjet C; Breitborde NJK; Brugha T; Dai X; Dandona L; Dandona R; Fischer F; Haagsma JA; Maria Haro J; Kieling C; Knudsen AKS; Kumar GA; Leung J; Majeed A; Mitchell PB; Moitra M; Mokdad AH; Molokhia M; Patten SB; Patton GC; Phillips MR; Soriano JB; Stein DJ; Stein MB; Szoeke CE; Naghavi M; Hay S; Murray CJL; Vos T; Whiteford HA, 2022, 'Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019', LANCET PSYCHIATRY, 9, pp. 137 - 150, http://dx.doi.org/10.1016/S2215-0366(21)00395-3

Price O; Man N; Bruno R; Dietze P; Salom C; Lenton S; Grigg J; Gibbs D; Wilson T; Degenhardt L; Chan R; Thomas N; Peacock A, 2022, 'Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016–20', Addiction, 117, pp. 182 - 194, http://dx.doi.org/10.1111/add.15620

Hammoud MA; Wells N; Holt M; Bavinton B; Jin F; Maher L; Philpot S; Haire B; Degenhardt L; Bourne A; Saxton P; Keen P; Storer D; Prestage G, 2022, 'COVID-19 Testing in a Weekly Cohort Study of Gay and Bisexual Men: The Impact of Health-Seeking Behaviors and Social Connection', AIDS and Behavior, 27, pp. 948 - 956, http://dx.doi.org/10.1007/s10461-022-03831-1

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Back to profile page